Citadel Advisors’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.22M | Sell |
|
|||||
|
2025
Q2 | $18.1M | Buy |
|
|||||
|
2025
Q1 | $15.7M | Buy |
|
|||||
|
2024
Q4 | $16M | Sell |
|
|||||
|
2024
Q3 | $34.4M | Buy |
|
|||||
|
2024
Q2 | $21.7M | Buy |
|
|||||
|
2024
Q1 | $3.16M | Buy |
|
|||||
|
2023
Q4 | $329K | Sell |
|
|||||
|
2023
Q3 | $538K | Buy |
|
|||||
|
2023
Q2 | $155K | Sell |
|
|||||
|
2023
Q1 | $502K | Sell |
|
|||||
|
2022
Q4 | $1.31M | Sell |
|
|||||
|
2022
Q3 | $1.81M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $2.97M | Buy |
|
|||||
|
2021
Q4 | $1.54M | Buy |
|
|||||
|
2021
Q3 | $1.36M | Sell |
|
|||||
|
2021
Q2 | $1.34M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $302K | Sell |
|
|||||
|
2020
Q3 | $8.56M | Buy |
|